HIMS From Distribution to Infrastructure

AfraSimon
01-26 07:09

Peptides are the next major health trend.

Haven’t seen google search interest accelerate this fast since pokemon go.

This is a major part of the bull case for $Hims & Hers Health Inc.(HIMS)$ .

If $Novo-Nordisk A/S(NVO)$ & $Eli Lilly(LLY)$ are the producers, then $HIMS is a distribution layer.

But it's planning to be more than that.

Roughly 1 year ago, HIMS acquired a US-based peptide facility.

Meaning HIMS is not just selling peptides anymore...it's building infrastructure to manufacture + control them.

It's emerging as one of the largest consumer distribution channels for GLP-1 drugs in the US.

HIMS is building a GLP-1 business that's approaching $700M+ in annual run rate.

And GLP-1 are just one class of peptides.

Not going too deep here. You don’t need to.

Peptides searches are up 144% since last year, per google trends data.

Demand is there.

Some argue that "insiders are selling", but the reality is that it's almost completely dried up since October '25, per @finviz_com.

Insider selling has slowed materially...unusual.cc'ing @TheLongInvest on this.

This is more bullish than anything...it's a change in character from insiders.

Approaching a highly attractive entry area around $25-$26 on HIMS, currently $29.62.

If the peptide boom is real + sticky, it can structurally re-price HIMS in 2026 imo.

For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs.

🎉Cash Boost Account Now Supports 35,000+ Stocks & ETFs – Greater Flexibility Now

Find out more here.

Complete your first Cash Boost Account trade with a trade amount of ≥ SGD1000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.

Click to access the activity

Other helpful links:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment